Bimeda Animal Health Ltd is pleased to announce the relaunch of their Bimoxyl LA 150mg/ml suspension for injection, containing 150mg/ml amoxicillin.
The product is licensed for use in cattle, sheep, pigs and dogs for the treatment of infections caused by amoxicillin-susceptible bacteria.
Bimeda Ireland General Manager, Andrew Glynn, commented, 'we are pleased to announce the relaunch of Bimoxyl LA Suspension for Injection, which was historically a popular choice among many vets in Ireland, due to the ease of use afforded through its excellent syringeability. Bimoxyl LA is also a category D antibiotic, which should be used as first line treatments, wherever possible, in accordance with the European Medicine Agency's guidance on the prudent use of antibiotics.
Key product features and benefits include;
- Short milk withdrawal for dairy cattle of 72 hours
- Short meat withdrawal periods of 21 days for sheep, 21 days for pigs and 18 days for cattle
- Broad spectrum antibiotic which covers gram-positive and gram-negative bacteria
- Excellent syringeability
- Licensed for use in dogs
- Shatterproof bottle
Mr Glynn also spoke about the sustainability credentials of the product, noting, 'we are also pleased to announce that Bimoxyl LA will now be supplied in a shatterproof PET plastic bottle. This bottle is 79% lighter than the previous glass vial, requiring less energy for transportation and incineration. We have moved the site of manufacture for Bimoxyl LA from California to Europe, which also reduces the distance this product travels by over 7,000 kilometres.'
Bimoxyl LA is available in a 100ml pack size and is a Prescription Only Medicine.
For more information, speak to your Bimeda representative, order via your wholesaler or call Bimeda on 01 4766 7941Enter your text here ...
Use Medicines Responsibly.
Full product information can be found on the SPC which is located on the HPRA website, or on the data sheet which is hosted at on bimeda.ie